GEA
CAH icon

Glen Eagle Advisors’s Cardinal Health CAH Stock Holding History

Glen Eagle Advisors’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.2K Buy
131
+67
+105% +$13.9K ﹤0.01% 531
2026
Q1 		$13.6K Hold
64
– – ﹤0.01% 624
2025
Q4 		$13.2K Buy
64
+5
+8% +$941 ﹤0.01% 646
2025
Q3 		$9.26K Buy
59
+29
+97% +$4.48K ﹤0.01% 704
2025
Q2 		$5.04K Hold
30
– – ﹤0.01% 726
2025
Q1 		$4.13K Hold
30
– – ﹤0.01% 754
2024
Q4 		$3.55K Hold
30
– – ﹤0.01% 794
2024
Q3 		$3.32K Hold
30
– – ﹤0.01% 837
2024
Q2 		$2.95K Hold
30
– – ﹤0.01% 841
2024
Q1 		$3.36K Buy
+30
New +$3.24K ﹤0.01% 839
2018
Q2 		– Sell
-195
Closed -$12.2K – 692
2018
Q1 		$12.2K Buy
195
+17
+10% +$1.17K 0.01% 414
2017
Q4 		$10.9K Hold
178
– – 0.01% 417
2017
Q3 		$11.9K Sell
178
-181
-50% -$12.8K 0.01% 410
2017
Q2 		$28K Buy
359
+178
+98% +$13.4K 0.02% 265
2017
Q1 		$14.8K Buy
181
+175
+2,917% +$13.8K 0.01% 323
2016
Q4 		$432 Buy
+6
New +$434 ﹤0.01% 531

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Glen Eagle Advisors's CAH Position: Q2 2026 in Review

Glen Eagle Advisors increased its Cardinal Health (CAH) stake by 105% in Q2 2026, buying an estimated $13.9K and bringing the position to 131 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #531.

Glen Eagle Advisors first reported a position in CAH in Q4 2016 and has held it in 16 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Glen Eagle Advisors held 131 shares of Cardinal Health worth $31.2K as of Q2 2026.
  • Glen Eagle Advisors bought 67 Cardinal Health shares in Q2 2026, an estimated $13.9K.
  • Cardinal Health made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #531 holding.
  • Glen Eagle Advisors first reported a position in Cardinal Health in Q4 2016 and has held it in 16 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.